Clinical Trial Update: Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations [Phase 2]

View source ↗

Summary

This is a completed Phase 2 efficacy and safety proof-of-concept trial in patients with Parkinson's disease experiencing end-of-dose motor fluctuations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED